A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.
Wong LM, Alibhai SM, Trottier G, Timilshina N, Van der Kwast T, Zlotta A, Lawrentschuk N, Kulkarni G, Hamilton R, Ferrara S, Margel D, Trachtenberg J, Jewett MA, Toi A, Evans A, Fleshner NE, Finelli A.
Wong LM, et al.
Eur Urol. 2014 Sep;66(3):406-13. doi: 10.1016/j.eururo.2013.04.038. Epub 2013 May 2.
Eur Urol. 2014.
PMID: 23664820